These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7138066)

  • 81. Screening for cystic fibrosis by a stool trypsin method.
    Forrest DC; Wilcken B; Turner G
    Arch Dis Child; 1981 Feb; 56(2):151-3. PubMed ID: 7469468
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Diagnosis of cystic fibrosis by means of genetic technology--guidelines from an expert meeting].
    Wahlström J; Annerén G; Anvret M; Bröndum-Nielsen K; Dahl N; Gustavson KH; Holmberg L; Holmgren G; Kollberg H; Kristoffersson U
    Lakartidningen; 1990 Oct; 87(42):3429-30. PubMed ID: 2233020
    [No Abstract]   [Full Text] [Related]  

  • 85. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 86. Mass screening for cystic fibrosis heterozygotes: two assay systems compared.
    Gilfillan A; Axton R; Brock DJ
    Clin Chem; 1994 Feb; 40(2):197-9. PubMed ID: 8313593
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis.
    Asch DA; Hershey JC; Pauly MV; Patton JP; Jedrziewski MK; Mennuti MT
    Am J Public Health; 1996 May; 86(5):684-90. PubMed ID: 8629720
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Active cascade screening for cystic fibrosis.
    Marteau T
    BMJ; 1994 Jun; 308(6942):1468. PubMed ID: 8019279
    [No Abstract]   [Full Text] [Related]  

  • 89. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Simple method for cystic fibrosis carrier screening.
    Molina Cabañero JC; Perez Jurado LA; Raskin S; Vicario JL; Balas Perez A; Garcia Novo MD
    Lancet; 1992 Oct; 340(8825):983-4. PubMed ID: 1357395
    [No Abstract]   [Full Text] [Related]  

  • 91. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
    Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
    J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetic counselling issues in cystic fibrosis.
    Culling B; Ogle R
    Paediatr Respir Rev; 2010 Jun; 11(2):75-9. PubMed ID: 20416541
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women.
    Botkin JR; Alemagno S
    Am J Public Health; 1992 May; 82(5):723-5. PubMed ID: 1566951
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Original research: parents and children with cystic fibrosis.
    Lomas PH; Fowler SB
    Am J Nurs; 2010 Aug; 110(8):30-7; quiz 38-9. PubMed ID: 20671493
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Screening for cystic fibrosis. Should begin with cascade screening.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Oct; 309(6958):877-8. PubMed ID: 7950637
    [No Abstract]   [Full Text] [Related]  

  • 96. A case for cystic fibrosis carrier testing in the general population.
    McClaren BJ; Metcalfe SA; Amor DJ; Aitken M; Massie J
    Med J Aust; 2011 Feb; 194(4):208-9. PubMed ID: 21401469
    [No Abstract]   [Full Text] [Related]  

  • 97. Cystic fibrosis carrier population screening: a review.
    Rowley PT; Loader S; Levenkron JC
    Genet Test; 1997; 1(1):53-9. PubMed ID: 10464626
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Neonatal screening for cystic fibrosis].
    Lucidi V; Lelli A; Castro M; Bella S; Ciuffetti C; Ravet P; Orrù M; Angeloni U; Angeloni P
    Pediatr Med Chir; 1994; 16(5):445-8. PubMed ID: 7885953
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
    Haddow JE; Bradley LA; Palomaki GE; Doherty RA
    J Med Screen; 1999; 6(2):60-6. PubMed ID: 10444721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.